
ADVERSE EVENT REPORTING GUIDELINES Document Version: 2.1 Effective Date: January 2024

DEFINITIONS:

Adverse Event (AE): Any untoward medical occurrence in a patient administered a pharmaceutical product, which does not necessarily have a causal relationship with the treatment.

Serious Adverse Event (SAE): An adverse event that:

- Results in death
- Is life-threatening
- Requires inpatient hospitalization or prolongation of existing hospitalization
- Results in persistent or significant disability/incapacity
- Is a congenital anomaly/birth defect
- Is a medically important event

SEVERITY GRADING: Grade 1 (Mild): Symptoms causing no or minimal interference with usual social and functional activities Grade 2 (Moderate): Symptoms causing greater than minimal interference with usual social and functional activities Grade 3 (Severe): Symptoms causing inability to perform usual social and functional activities Grade 4 (Life-threatening): Symptoms causing urgent intervention indicated Grade 5 (Fatal): Death related to adverse event

REPORTING TIMELINES:

- Serious Adverse Events: Report within 24 hours of awareness
- Non-serious Adverse Events: Report at next scheduled visit
- Pregnancy: Report within 24 hours of awareness

CAUSALITY ASSESSMENT: Relationship to study drug must be assessed as:

- Not Related: No temporal relationship or alternative cause clearly explains the event
- Unlikely: Temporal relationship exists but alternative cause more likely
- Possible: Temporal relationship exists and alternative cause possible but less likely
- Probable: Temporal relationship exists and no alternative cause identified
- Definite: Clear temporal relationship and rechallenge positive (if applicable)

DOCUMENTATION REQUIREMENTS: All adverse events must be documented with:

- Event description
- Start and end dates
- Severity grade
- Causality assessment
- Action taken (dose modification, treatment, etc.)
- Outcome (resolved, ongoing, fatal, etc.)

FOLLOW-UP: All adverse events must be followed until resolution or stabilization. Serious adverse events require detailed narrative reports.
